Présentation de Dialin : réseau de surveillance des infections chez les patients hémodialysés en centre. Premiers résultats

Ayzac, Louis; Beruard, M; Girard, R.; Hannoun, Jacques; François, Kuentz; Marc, Jean-Michel; Moreau-Gaudry, Xavier; Roche, Catherine; Tressières, Benoît; Marc, Uzan

doi:10.1016/j.nephro.2008.06.003

Cited by 2 publications

(3 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… N Prevalence (%) Ref. Prevalence* (%) France 3 7.7–16.3 [31] , [44] , [45] 1 a 1.4–3.2 [27] 2 d 8.2–47.1 [23] , [27] 3 g 2.1–8.2 [27] 0.8 Germany 2 3.6–5.2 [46] , [47] 1 b 11.3 [48] 0.4 Greece 2 24–29 [32] , [33] 2 e 2–54.2 [22] , [49] 2.2 Italy 2 15.1–18.8 [34] , [35] 1 c 8.9 [50] 4 f 35.5–95.4 [21] , [51] 1 5.9 <...>…”

Section: Resultsmentioning

confidence: 99%

“… N Incidence Ref. France 2 0–0.4 [31] , [44] Germany 1 0 [47] Greece 1 6.2 [33] Italy 1 2.5 [34] 1 a 0 [57] 1 0 [40] UK 2 0–2.6 [41] , [42] EU/EEA 7 2.4–6.2 1 0 1 0 N, number of included studies. a Endoscopy patients.…”

Section: Resultsmentioning

confidence: 99%

“…Possibly due to the challenges in investigating incidence, studies reporting on HCV new infections among population groups at risk of iatrogenic transmission are few with limited geographic coverage and largely conducted more than a decade ago, posing some concerns on the applicability of the findings to the present context. Older studies from France, Greece, Italy and the UK present evidence of HCV transmission among haemodialysis patients, while more recent ones detected no incident cases [41] , [44] , [47] , and one Italian study specifically referred to no case of seroconversion occurring after 1986 [21] . This is very likely due to an improvement in the application of infection-control procedures [45] , [64] .…”

Section: Discussionmentioning

confidence: 97%

See 2 more Smart Citations

Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area

Tavoschi

Mason²,

Petriti³

et al. 2019

Journal of Hospital Infection

View full text Add to dashboard Cite

Summary In the European Union/European Economic Area (EU/EEA) approximately 9 million people are chronically infected with hepatitis B virus (HBV) or hepatitis C virus (HCV), and many are undiagnosed. Targeted active case finding initiatives are needed. Iatrogenic transmission of HBV/HCV is relevant in Europe but people at risk of infection are often overlooked. This study aimed to identify groups at increased risk of HBV/HCV infection due to iatrogenic transmission, including healthcare workers, and to estimate incidence and prevalence. PubMed and Embase were systematically searched in February 2017 using strings combining terms for HBV/HCV, occurrence and population subgroups. All retrieved publications were screened and included articles were quality assessed. A predefined set of variables were extracted, and detailed summary tables were developed per population group of interest, virus and outcome. Thirty-eight articles were included, two reported on HBV, 22 on HCV and 16 on both, contributing 70 estimates of prevalence or incidence among: haemodialysis recipients, diabetes patients, recipients of substances of human origin, recipients of medical/dental procedures and healthcare workers. Estimates varied widely from 0.4% to 11.7% for HBV and from 0.7% to over 90% for HCV with most being higher than in the general population. Despite the limited number of studies retrieved, mostly old and focused on populations with multiple risk factors, our findings highlight the importance of considering population groups at higher risk for HBV/HCV iatrogenic transmission as target groups for active case finding in the EU/EEA. Test offers should be guided by individual risk assessment alongside local epidemiological data and local context.

show abstract